Viraleze with good management and distributer , should this trial actually be sucessful , at least has a obvious pathwaty to generate some cash flow. That cash flow could underpin and support the market price . All assumptions if the confirmatory study is suitably powered or can lead to a IMO decent study that will actually progress approval and distribution elsewhere.
IMO it is hard to stuff up a product so badly but between BV and VZ they have a 100% record of poor performance to date in regards to sale and distribution.
The assumptions to underpin market cap are based on teh fact that only a small amount needs to be funded in further legal and trilas to get some more sales / approvals
Ann: Positive DEP docetaxel Phase 2 results, page-39
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(0.51%) |
Mkt cap ! $41.52M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $9.709K | 97.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 384741 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 493798 | 2 |
View Market Depth
| Last trade - 14.36pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |